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ABSTRACT 
OBJECTIVE: To analyze the prevalence and factors associated with smoking 
abstinence among patients who were treated in a reference unit for smoking 
cessation.
METHODS: This cross-sectional study examined the medical records of 
532 patients treated in a reference unit for smoking cessation in Belém, PA, 
Northern Brazil, between January 2010 and June 2012. Sociodemographic 
variables and those related to smoking history and treatment were analyzed. 
Statistical significance was set at p < 0.05. 
RESULTS: The mean age of the participants was 50 years; 57.0% of the 
patients were women. The mean tobacco load was 30 packs/year, and the 
mean smoking duration was approximately 32 years. Most patients remained 
in treatment for four months. The rate of smoking abstinence was 75.0%. 
Regression analysis indicated that maintenance therapy, absence of relapse 
triggers, and lower chemical dependence were significantly associated with 
smoking cessation.
CONCLUSIONS: The smoking abstinence rate observed was 75.0%. 
The cessation process was associated with several aspects, including the 
degree of chemical dependence, symptoms of withdrawal, and period of 
patient follow-up in a multidisciplinary treatment program. Studies of this 
nature contribute to the collection of consistent epidemiological data and 
are essential for the implementation of effective smoking prevention and 
cessation strategies. 
DESCRIPTORS: Substance Withdrawal Syndrome, epidemiology. 
Smoking Cessation. Tobacco Use Cessation. Smoking, therapy. 
Cross-Sectional Studies.
Original Articles DOI:10.1590/S0034-8910.2015049004946
Samires Avelino de Souza 
FrançaI
Ana Ligian Feitosa das NevesI
Tatiane Andressa Santos de 
SouzaI
Nandara Celana Negreiros 
MartinsI
Saul Rassy CarneiroI
Edilene do Socorro Nascimento 
Falcão SargesI
Maria de Fátima Amine Houat 
de SouzaII
2 Factors associated with smoking cessation França SAS et al
Smoking is an important public health problem. 
Tobacco dependence is a complex process that involves 
the pharmacological action of nicotine (physical 
dependence); conditionings and acquired behavioral 
processes (behavioral dependence); and factors related 
to personality, emotional expressions, and social condi-
tions (psychological dependence).a
Smoking cessation is an efficient and cost-effective 
intervention because it promotes a significant reduction 
in morbidity and mortality rates.b Therapeutic strategies 
that can be used for smoking cessation include phar-
macological treatments (particularly nicotine replace-
ment and bupropion), combined with behavioral and 
individualized approaches, also known as cognitive-
behavioral therapy.2,17
Considering that most studies on tobacco control in 
Brazil contain specific population profiles,4,20 knowing 
the profile of smokers in the context of the main 
RESUMO
OBJETIVO: Analisar a prevalência e fatores associados à abstinência tabágica 
entre pacientes atendidos em unidade de referência para cessação do tabagismo.
MÉTODOS: Estudo transversal que analisou 532 prontuários de pacientes 
atendidos em unidade de referência para cessação do tabagismo em Belém, 
PA, entre janeiro de 2010 e junho de 2012. Foram analisadas variáveis 
sociodemográficas e  aquelas relacionadas à história tabágica e ao tratamento 
realizado. Considerou-se para significância estatística p < 0,05. 
RESULTADOS: A média de idade dos participantes foi 50 anos e cerca de 57,0% 
dos pacientes eram do sexo feminino. A carga tabágica média foi 30 maços/ano 
e o tempo médio de tabagismo foi aproximadamente 32 anos. A maioria dos 
pacientes permaneceram em tratamento por quatro meses. A taxa de abstinência 
tabágica foi 75,0%. Na análise de regressão, terapia de manutenção, ausência de 
gatilhos de recaída e dependência química mais baixa foram significativamente 
associados à cessação.
CONCLUSÕES: A taxa de abstinência tabágica observada foi 75,0%. O 
processo de cessação associou-se a diversos aspectos, como grau de dependência 
química, sintomas de abstinência e tempo de acompanhamento do paciente em 
um programa de tratamento multiprofissional. Estudos desta natureza, portanto, 
auxiliam na reunião de informações epidemiológicas consistentes, fundamentais 
à elaboração de ações de prevenção e combate ao tabagismo mais efetivas. 
DESCRITORES: Síndrome de Abstinência a Substâncias, epidemiologia. 
Abandono do Hábito de Fumar. Abandono do Uso de Tabaco. Hábito de 
Fumar, terapia. Estudos Transversais.
INTRODUCTION
difficulties associated with smoking cessation allows 
for more effective treatments.
The present study aimed to analyze the prevalence 
of the factors associated with smoking abstinence 
among patients who were treated at a reference unit 
for smoking cessation.
METHODS
The study was conducted at the Centro de Referência 
Especializado em Abordagem e Tratamento do Fumante 
(CREATF – Reference Centre Specialized in the 
Approach and Treatment of Smokers), in Belém, PA, 
Northern Brazil, which is linked to the Pará State Health 
Secretariat. The CREATF serves patients by sponta-
neous demand or referral by the municipal health units. 
The CREATF treated approximately 3,500 patients 
during its 10 years of operation.
a Rosemberg J, Rosemberg AMA, Moraes MA. Nicotina: droga universal. São Paulo: Secretaria de Saúde do Estado de São Paulo, Centro de 
Vigilância Epidemiológica; 2003. 
b World Health Organization. Report on the Global Tobacco Epidemic, 2008: the MPOWER package. Geneva; 2008 [cited 2012 Dec]. 
Available from: http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdf
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This cross-sectional study examined the medical records 
of patients enrolled in the smoker attention program 
at the CREATF between January 2010 and June 2012. 
During this period, 593 individuals sought the help of the 
CREATF for smoking cessation. Smoking histories with 
incomplete or incoherent data were excluded from the 
analysis, as well as those not retrieved after three attempts. 
A total of 61 records were excluded. Therefore, the study 
sample comprised 532 records of patients who attended at 
least two sessions of cognitive-behavioral therapy.
Sociodemographic data, smoking history, treatments 
performed, and outcome obtained within the aforemen-
tioned program were collected. The aspects related to 
smoking history included number of cigarettes/day, levels 
of chemical dependence levels, attempts of smoking cessa-
tion, and presence of triggers (any physical, chemical, 
psychological, or behavioral factors that can induce the 
consumption of cigarettes, leading to a lapse or relapse). 
The variables related to treatment and its outcome were 
reported withdrawal symptoms, treatments performed 
(behavioral and/or medical approach), physical activity 
practice, and treatment outcome (the time when the patient 
ceased to be monitored at the CREATF).20
The following sociodemographic variables were included 
in the statistical analysis: sex, age, educational level, and 
occupational status. To simplify the statistical analysis, 
some variables were stratified. Education was stratified 
as “up to eight years of education” (this group included 
illiterate and semi-literate individuals) and “more than 
eight years of education”; occupational status was strati-
fied as “individuals without a source of income” (unem-
ployed), “individuals with a source of income” (formal 
or informal employment), and “retirees”.
The number of cigarettes/day was stratified as “up to 
20 cigarettes/day” and “more than 20 cigarettes/day”. 
Chemical dependence was characterized according to 
the Fagerstrom Scale and stratified into “very low to 
medium” and “high to very high”. The variable “cessa-
tion attempts” was divided into patients who attempted 
smoking cessation and those who never attempted. The 
triggers associated with smoking habit were classified 
as behavioral, psychological, chemical, or their associa-
tions thereof; triggers leading to relapse were stratified 
according to the absence of triggers, the presence of a 
single trigger, and association of triggers. Regarding 
the abstinence syndrome, the patients were divided 
into those with up to two reported symptoms and those 
with more than two complaints. Regarding the treat-
ments conducted, the patients were divided into those 
who underwent cognitive-behavioral therapy only (and 
did not require drug support) and those who, in addi-
tion to cognitive-behavioral therapy, required other 
therapeutic strategies (nicotine replacement or laser 
therapy). Treatment outcome was defined as the time 
of the last contact with the CREATF (as registered in 
the medical history) for cognitive-behavioral therapy 
or maintenance therapy.
Each post-treatment patient was classified as teetotaler 
or smoker, according to the most recent record in their 
medical history; the last analysis variable was “smoking 
status at the end of the treatment”, which indicated the 
rate of success and failure of treatment.
Data were tabulated and organized in spreadsheets. 
Statistical analysis was performed using EpiInfo soft-
ware, version 3.5.2. The frequencies of the variables 
and their respective confidence intervals were included, 
and raw and adjusted analyses were included for deter-
mination of the variables associated with the final status 
of the patients who underwent the treatment. The statis-
tical significance level was set at p < 0.05.
This study was approved by the Research Ethics 
Committee of the Fundação Pública Estadual Hospital 
de Clínicas Gaspar Vianna (Protocol 001795), in accor-
dance with the guidelines for human research established 
by Resolution 196/96 of the National Health Council. 
The patients were identified by their respective medical 
history numbers in order to preserve their identity.
RESULTS
The mean age of individuals were treated at the 
CREATF was 49.73 years. Most individuals in the study 
group were women (56.6%). The total study group and 
the prevalence of teetotalers and smokers, according 
to sociodemographic variables, smoking history, and 
treatments performed are listed in Table 1.
The tobacco load was, on average, 30 packs/year; the 
mean smoking duration was 32.4 years. The success rate 
of the intervention was 75.0% in the period evaluated. 
On average, teetotalers were monitored for up to four 
months after smoking cessation, and the control and 
maintenance periods reached up to 33 months when 
their contact with the CREATF ended.
No sociodemographic variable was significantly 
associated with the status at the end of treat-
ment (p > 0.05; Table 2). The analysis of smoking 
history and the treatments performed indicated that all 
variables were statistically significant, except number of 
cessation attempts and triggers (Table 3). The variables 
stratified by status at the end of treatment (teetotaler 
and smoker) with p < 0.2 were selected for raw analysis 
(Table 4). Physical activity, treatment outcome, nicotine 
addiction, relapse triggers, number of cigarettes/day, 
and the treatments performed were statistically signifi-
cant (p < 0.05) variables and therefore, were subjected 
to adjusted analysis. The duration of participation in 
the program, presence of relapse triggers, and high or 
very high status of addiction appeared to influence the 
cessation process (Table 5).
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Table 1. Profile of the study group and prevalence of teetotalers and smokers, according to sociodemographic variables, smoking 
history, and treatments. Belém, PA, Northern Brazil, 2012.
Variable
Total population Teetotalers Smokers
   
N (532) % N (399) % N (133) %
Sex
Feminine 301 56.6 224 74.4 77 25.6
Masculine 231 43.4 175 75.8 56 24.2
Education (years of study)
≤ 8 194 36.5 149 76.8 45 23.2
> 8 338 63.5 250 74.0 88 26.0
Occupational status
Formal or informal employment 385 72.4 285 74.0 100 26.0
Aposentado 63 11.8 50 79.4 13 20.6
Desempregado 84 15.8 64 76.2 20 23.8
Cigarettes/day
≤ 20 382 71.8 298 78.0 84 22.0
> 20 150 28.2 101 67.3 49 32.7
Chemical dependence (Fagerstrom)
Very low to medium 243 45.7 193 79.4 50 20.6
High to very high 289 54.3 206 71.3 83 28.7
Cessation attempts
Yes 449 84.4 339 75.5 110 24.5
No 83 15.6 60 72.3 23 27.7
Trigger
Chemical 5 0.9 4 80.0 1 20.0
Psychological 71 13.3 57 80.3 14 19.7
Behavioral 454 85.3 336 74.0 118 26.0
Associations 2 0.4 2 100.0 0 0.0
Treatment used
CBT 111 20.9 68 61.3 43 38.7
CBT + others 421 79.1 331 78.6 90 21.4
Withdrawal symptoms
≤ 2 334 62.8 228 68.3 106 31.7
> 2 198 37.2 171 86.4 27 13.6
Treatment outcome
CBT 234 44.0 116 49.6 118 50.4
MT 298 56.0 283 95.0 15 5.0
Relapse trigger
Absent 485 91.2 378 77.9 107 22.1
One trigger 38 7.1 16 42.1 22 57.9
Trigger associations 9 1.7 5 55.6 4 44.4
Physical activity
Yes 110 20.7 307 72.7 115 27.3
No 422 79.3 92 83.6 18 16.4
CBT: cognitive-behavioral therapy; MT: maintenance therapy
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Table 2. Frequency and analysis of sociodemographic variables, according to patient status after treatment for smoking cessation. 




% 95%CI % 95%CI
Prevalence 75.0 71.1;78.6 25.0 21.4;28.9
Sex 0.40
Feminine 56.2 51.1;61.1 57.9 49.0;66.4
Masculine 43.9 38.9;48.9 42.1 33.6;51.0
Education (years of study) 0.24
≤ 8 36.2 31.5;41.2 32.3 24.4;41.1
> 8 63.8 58.8;68.5 67.7 58.9;75.6
Occupational status 0.33
Formal or informal employment 70.4 65.6;74.8 72.2 63.7;79.6
Retiree 12.5 9.5;16.3 9.8 5.3;16.1
Unemployed 16.0 12.7;20.1 15.0 9.4;22.3
Table 3. Frequency and analysis of variables associated with smoking history and treatment used, according to patient status 




% 95%CI % 95%CI
Cigarettes/day < 0.01
≤ 20 74.7 70.1;78.8 63.2 54.4;71.4
> 20 25.3 21.2;29.9 36.8 28.6;45.6
Chemical dependence (Fagerstrom) < 0.05
Very low to medium 46.9 41.9;52.0 36.6 28.4;45.5
High to very high 53.1 48.0;58.1 63.4 54.5;71.6
Cessation attempts 0.44
Yes 84.9 81.0;88.3 82.6 75.0;88.6
No 15.1 11.8;19.1 17.4 11.4;25.0
Trigger 0.95
Chemical 1.0 0.3;2.7 0.8 0.0;4.1
Psychological 14.3 11.1;18.2 10.5 5.9;17.0
Behavioral 84.2 80.3;87.6 88.7 82.1;93.5
Associations 0.3 0.0;1.6 0.0 0.0;2.7
Treatment used < 0.01
CBT 17.0 13.6;21.2 31.6 23.8;40.2
CBT + others 83.0 78.9;86.5 67.7 59.0;75.5
Withdrawal symptoms < 0.01
≤ 2 44.7 39.8;49.8 45.1 36.5;54.0
> 2 43.0 38.1;48.0 20.3 13.8;28.1
Treatment outcome < 0.01
CBT 29.1 24.7;33.8 88.7 82.1;93.5
MT 70.9 66.2;75.3 11.3 6.5;12.9
Relapse trigger < 0.01
Absent 80.2 72.3;86.6 94.7 91.8;96.6
One trigger 16.8 10.8;24.3 4.1 2.4;6.6
Trigger associations 3.1 0.8;7.6 1.3 0.5;3.1
Physical activity < 0.05
Yes 23.1 19.1;27.6 13.5 8.2;20.5
No 76.9 72.4;80.9 86.5 79.5;91.8
CBT: Cognitive-behavioral therapy; MT: Maintenance therapy
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DISCUSSION
The abstinence rate at the CREATF in Belém was 75.0%, 
which is considered high when compared with the rate 
from other national studies14,20 and with the profile of 
patients who were treated in other health care units. 
The main factor associated with the success or failure of 
treatment was the participation in maintenance therapies, 
which appeared to favor abstinence, whereas the pres-
ence of relapse triggers and high or very high chemical 
dependence were complicating factors in this process.
Mazoni et al11 (2008) observed that pharmacotherapy 
doubles the probability of abstinence.3,8 However, these 
authors found that the association between drug therapy 
and cognitive-behavioral therapy is not statistically 
significant for the maintenance of abstinence.
Patients who underwent maintenance behavioral 
therapy presented a 27-fold higher probability of 
maintaining abstinence when compared with those 
who underwent only cognitive-behavioral therapy. 
Iliceto et al9 (2013) reinforced the importance of patient 
follow-up even after smoking cessation, considering 
that the risk of relapse is the highest in the initial phase.
Maintenance therapy aims to keep patients motivated 
to maintain abstinence because the chances of relapse 
are strongly associated with the lack of motivation and 
low attendance in therapy sessions.18
In the present study, the average follow-up period 
after smoking cessation was four months. However, 
the Guidelines for Tobacco Cessation of the Brazilian 
Society of Pneumology and Tisiology17 (2008) suggest 
that the patient’s smoking cessation process should 
be monitored for at least six months.17 Therefore, it is 
important to resort to strategies that support maintenance 
therapy for a period longer than that reported herein.
Yong et al22 (2010) emphasized the importance of moni-
toring patients for more than six months after smoking 
cessation through outpatient consultation and telephone 
contacts in order to monitor the difficulties faced by the 
patients and to praise their progress.
The results demonstrated that the presence of a trigger, 
understood as a factor that motivates smoking, acts 
as a deterrent to smoking cessation because it predis-
poses to relapse. According to Cardoso et al6 (2010), 
the occurrence of relapse is correlated with sociode-
mographic variables and the level of addiction; the 
present study evaluated whether the presence or 
absence of triggers in the face of relapse was associ-
ated with patient status at the end of treatment.
Table 4. Raw analysis of the studied variables associated with smoking abstinence at the end of treatment. Belém, PA, Northern Brazil, 2012.
Variable OR 95%CI p
Physical activity 0.93 0.87;0.98 < 0.05
Treatment outcome 19.19 10.75;34.24 < 0.01
Nicotine addiction (Fagerstrom) 0.65 0.43;0.98 < 0.05
Relapse triggers 0.34 0.20;0.57 < 0.01
Number of cigarettes 0.58 0.38;0.88 < 0.05
Symptoms 0.96 0.84;1.09 0.54
Treatment used 2.35 1.51;3.65 < 0.01
Table 5. Adjusted analysis of the studied variables associated with patient status at the end of treatment (teetotaler or smoker). 
Belém, PA, Northern Brazil, 2012.
Variable OR 95%CI p
Treatment outcome < 0.01
CBT 1.00 13.18;58.54
MT 27.77
Relapse triggers < 0.01
Absent 1.00 0.02;0.18
One 0.52
Chemical dependence (Fagerstrom) < 0.05
Very low to medium 1.00 0.29;0.96
High to very high 0.52
CBT: Cognitive-behavioral therapy; MT: Maintenance therapy
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Ferguson & Shiffman7 (2010) reinforced the idea that 
the presence of triggers hinders the success rates of 
anti-smoking treatment. These authors highlighted that 
behavioral strategies toward triggers should be encour-
aged in all patients, regardless of their drug therapy status.
Furthermore, the high degree of addiction hinders the 
success rates of treatment, and moderate and severe 
dependence enhances withdrawal symptoms during 
smoking cessation, favoring long-term relapse.5,22
Father & Prasad13 (2012) evaluated two groups of 
smokers with similar sociodemographic characteristics 
and found that patients with low addiction benefited 
from cognitive-behavioral therapy, whereas those with 
a high degree of nicotine dependence required nicotine 
replacement therapy to achieve abstinence.
The success rate of the treatment offered by the 
CREATF was 75.0%, which can be considered high 
when compared with similar services in Brazil, 
with average rates of smoking cessation between 
40.0% and 50.0%.14,20,21 This information is relevant, 
considering the significant long-term smoking habit 
presented by the patients in this study. The history 
of smoking and duration of heavy smoking may have 
contributed to the patients’ awareness of their high 
degree of dependence, leading them to effectively 
engage in treatment.
According to Bortoluzzi et al4 (2011), being under 
40 years and having low income and lower education 
status are factors closely associated with maintenance 
of smoking and higher rates of failure.10,19 Nonetheless, 
the present study found no significant association 
between sociodemographic variables and status at the 
end of treatment.
Other studies observed the existence of heterogeneity in 
the sociodemographic variables associated with smoking 
cessation in different populations. Peixoto et al14 (2007), 
in a comparative analysis between the metropolitan 
region of Belo Horizonte and the town of Bambuí, both 
in MG, Southeastern Brazil, found very similar absti-
nence rates (40.0% and 38.8%, respectively). However, 
the factors associated with smoking cessation differed 
among these population groups.
Azevedo et al1 (2009) and Morissette et al12 (2007) 
found that the rate of failure and relapse is strongly 
associated with the presence of psychiatric symptoms, 
such as depression and anxiety. The present results 
showed no statistically significant association between 
the presence of these symptoms and failure of treatment. 
However, patients with psychiatric disorders were not 
analyzed individually.
With regard to the investigation of physical activity 
in similar programs, Prochaska et al16 (2008) argued 
that physical exercise reduces withdrawal symptoms, 
promoting smoking cessation. However, the results 
demonstrated that the records for this variable were 
incomplete. Therefore, it is suggested that this variable 
should be included in the standard evaluation form in 
order to optimize therapy.
The limitations of the present study are related to the 
collection of secondary data, underreporting of bias, 
and the self-reporting of abstinence, which may have 
over- or under-estimated the results. Furthermore, 
the cross-sectional nature of the study limited the 
establishment of causal relationships.15 However, 
such limitations are inherent to this type of study 
and therefore cannot be avoided. To minimize infor-
mation bias, only records with complete data were 
included in the analysis.
The identification of the main factors associated with 
successful treatment will allow a reassessment of the 
health strategies aimed at smokers. Patients with a 
higher degree of dependence and those who relapse 
during treatment require increased therapeutic support. 
In addition, maintenance therapies should be more 
dynamic to ensure full adherence to treatment.
Additional studies comparing and addressing popula-
tion changes that influence the success of treatment 
and further research to support smoking prevention 
and cessation initiatives are needed.
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